Axim Biotechnologies Inc (OTCQB:AXIM)

0.65
Delayed Data
As of Aug 23
 +0.02 / +3.17%
Today’s Change
0.46
Today|||52-Week Range
2.52
-13.33%
Year-to-Date
SECTOR
Industrial Services
INDUSTRY
Environmental Services
MARKET CAP
$40.6M

Company Description

AXIM Biotechnologies, Inc. is engaged in the research, development, and production of pharmaceutical, nutraceutical, cosmetic, and genetically controlled botanical products. It also involves in the extraction and purification of cannabinoids technologies based on its proprietary technologies. Its products include CBD-based controlled release chewing gum under CanChew brand; and a combination of CBD and THC gum that treats pain and spasticity associated with multiple sclerosis under MedChew Rx brand. The company was founded on November 18, 2010 and is headquartered in New York, NY.

Contact Information

AXIM Biotechnologies, Inc.
45 Rockefeller Plaza
New York New York 10111
P:(212) 332-1677
Investor Relations:

Employees

Shareholders

Individual stakeholders66.08%
Mutual fund holders0.00%
Other institutional0.00%

Top Executives

John W. HuemoellerChief Executive Officer & Director
Robert T. MalasekChief Financial Officer & Secretary
Lekhram ChangoerDirector & Chief Technology Officer
Philip A. van DammeDirector, Chief Scientific & Medical Officer